Selvaraj Nataraja

Selvaraj Nataraja

Company: Mitobridge/Astellas

Job title: Senior Director, Translational Research

Seminars:

Spotlight Session– BACH1 Inhibitor as Therapeutics for Sickle Cell Disease 9:30 am

Developing therapeutics modulating mitochondrial function to address various diseases Developing a BACH1 inhibitor that can regulate antioxidant response genes through Nrf2 pathway Reviewing the preclinical data supporting the therapeutic efficacy of BACH1 inhibitor to treat sickle cell diseaseRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.